Green light for acne drug Seysara in the US
US regulators have approved Paratek’s Seysara for the treatment of acne in patients aged nine years or older.
3rd October 2018
Latest news
EU nod for Lilly’s new breast cancer drug
Eli Lilly’s CDK 4 and 6 inhibitor Verzenios has been approved in Europe for the treatment of certain metastatic breast cancers.
3rd October 2018
GSK updates its HCP payment policy
GlaxoSmithKline is overturning a blanket ban on payments to doctors promoting its medicines, now allowing the practice under certain circumstances.
3rd October 2018
Digital health projects win £17 million
The government has unveiled the winning projects of the latest Digital Health Catalyst competition, which will each win a slice of £17 million handed out by the Industrial Strategy Challenge Fund to help fuel their progress.
2nd October 2018
Gov’t to unveil £240m extra social care funding
The government reportedly intends to stream an extra £240 million into social care services this winter to help alleviate pressures on the NHS.
2nd October 2018
Nobel prize awarded for research on cancer immunotherapy
US researcher James Allison and Japanese researcher Tasuku Honjo have won the 2018 Nobel Prize for Physiology or Medicine for their ground-breaking work on manipulating the immune system to combat cancer.
2nd October 2018
UK launch for Alliance’s pregnancy anti-nausea and vomiting drug
Alliance Pharma has announced the launch of Xonvea in the UK to treat nausea and vomiting of pregnancy (NVP) in women who do not respond to conservative management.
2nd October 2018
NHS England agrees to fund Janssen’s Symtuza
NHS England (NHSE) has agreed to provide funding for Janssen’s Symtuza, a once-daily darunavir-based single tablet regimen (STR), for the treatment of HIV in adults and adolescents.
1st October 2018
US OKs Sanofi, Regeneron’s new skin cancer immunotherapy
Sanofi and Regeneron’s imunotherapy Libtayo has been cleared in the US to treat patients with certain forms of cutaneous squamous cell carcinoma (CSCC).
1st October 2018
Shield files Feraccru with the FDA
The UK’s Shield Therapeutics has successfully submitted an application to market iron deficiency therapy Feraccru in the US.
1st October 2018
GP closures could have ‘catastrophic’ effect on patient care, says RCGP
GP leaders are warning that more than 2.5 million patients across England could see their GP practice close in the next five years because of the high number of family doctors at risk of leaving the profession.
1st October 2018
Lilly’s Emgality wins first nod for migraine prevention
The US Food and Drug Administration have green-lighted use of Eli Lilly’s non-opioid pain drug Emgality for the prevention of migraine.
28th September 2018
GW Pharma’s Epidiolex nears US launch
GW Pharmaceuticals and its subsidiary Greenwich Biosciences are gearing up to launch Epidiolex in the US after drug enforcement officials re-classified the cannabis-based medicine to the lowest restriction.
28th September 2018
NHS England pledges £10m to support GP services over winter
NHS England says it will provide £10 million to GPs to help support delivery of additional extended hours, out of hours and unscheduled care sessions over the winter period.
28th September 2018
US green light for Pfizer’s lung cancer drug
Pfizer’s pan-human epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor dacomitinib has been approved in the US as a treatment for some forms of lung cancer.
28th September 2018
